Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D002438:Cefoperazone / Q000627:therapeutic use*; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008712:Methicillin / Q000627:therapeutic use*; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use*; D010996:Pleural Effusion / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011897:Random Allocation; D013982:Ticarcillin / Q000627:therapeutic use*; D013997:Time Factors; D014031:Tobramycin / Q000627:therapeutic use*
D010406:Penicillins; D002438:Cefoperazone; D013982:Ticarcillin; D008712:Methicillin; D014031:Tobramycin